Latest News
News
Higher odds for preterm, C-section births seen in women with PsA
Pregnant women with psoriatic arthritis may have an increased risk for preterm birth or cesarean delivery if they are receiving antirheumatic...
News
Better COVID-19 outcomes confirmed in TNF inhibitor users
A study of three international registries confirms that patients with immune-mediated inflammatory diseases who are taking a TNF inhibitor should...
News
Few JAK inhibitor users have diminished immune response to COVID-19 vaccines
Most patients taking JAK inhibitors had seemingly adequate immune responses based on serologic assessment of detectable antibodies, but those...
News
Study of biologics’ impact on psoriasis-to-PsA transition contradicts previous findings
Differing patient selection criteria and other biases may be why results from a large EHR administrative database study contradict those from...
Latest News
European agency recommends two new adalimumab biosimilars
The Committee for Medicinal Products for Human Use gave a positive opinion for the approval of Hukyndra and Libmyris, each of which will have 15...
News
Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains high
Coverage of and access to biologics for psoriasis and psoriatic arthritis are compromised by out-of-pocket payments and prior authorization...
News
Cannabidiol found no better than placebo for hand arthritis pain
Patients with hand osteoarthritis or psoriatic arthritis who used cannabidiol as an add-on analgesic had results similar to those of placebo.
Conference Coverage
Psoriatic arthritis health care costs continue to rise over time
In a database claims review, the average person with PsA had higher inpatient, outpatient, and pharmacy costs, compared with those with only...
Conference Coverage
Physicians question the future of TNF inhibitors for psoriasis, PsA
Two dermatologists and two rheumatologists debate the merits of using IL-17 and IL-23 inhibitors ahead of TNF inhibitors for the treatment of...
News
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Significantly lower antibody concentrations seen after a first dose of the Pfizer or AstraZeneca vaccine in users of infliximab vs. vedolizumab...